Literature DB >> 25278280

Inflammatory mediators as predictors of outcome in perinatal asphyxia.

B Bharathi1, B Vishnu Bhat, V S Negi, B Adhisivam.   

Abstract

OBJECTIVES: To identify biomarkers for neuronal injury and outcome in perinatal asphyxia.
METHODS: This prospective cohort study was done in authors' level III NICU involving 80 neonates - 40 babies with perinatal asphyxia and 40 weight and gender matched normal neonates. Levels of cytokines IL-6, IL -1β, IL-2 and TNF -α in cord blood of these neonates were estimated and correlated with the severity of asphyxia and developmental outcome at 6 mo using Baroda Developmental Score.
RESULTS: The baseline parameters revealed that there was no statistically significant difference between the two groups in terms of maternal age, parity, gestational age, gender and birth weight. The levels of cytokines IL-6 (p < 0.001) and IL-1beta (p < 0.03) were significantly higher in babies with perinatal asphyxia and correlated with the severity of asphyxia. The levels of IL-6 and IL-1β had significant negative correlation with developmental score at 6 mo. A cut off level of 14.18 pg/ml for IL-6 had 92.3 % sensitivity and 57.7 % specificity [Area under the curve = 0.80 (0.62-0.84)] for adverse neuro-developmental outcome while it was 11.17 pg/ml for IL-1β with a sensitivity of 69.2 % and specificity of 71.2 % [Area under the curve = 0.67 (0.57-0.80)].
CONCLUSIONS: IL-6 and IL-1 β are good predictive markers of severity of asphyxia and adverse neurological outcome.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25278280     DOI: 10.1007/s12098-014-1575-4

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  16 in total

1.  IL-1beta, IL-6 and TNF-alpha and outcomes of neonatal hypoxic ischemic encephalopathy.

Authors:  Hany Aly; Mohamed T Khashaba; Mostafa El-Ayouty; Osman El-Sayed; Bothina M Hasanein
Journal:  Brain Dev       Date:  2005-09-21       Impact factor: 1.961

2.  Chemokine and inflammatory cell response to hypoxia-ischemia in immature rats.

Authors:  E Bona; A L Andersson; K Blomgren; E Gilland; M Puka-Sundvall; K Gustafson; H Hagberg
Journal:  Pediatr Res       Date:  1999-04       Impact factor: 3.756

3.  Human perinatal asphyxia: correlation of neonatal cytokines with MRI and outcome.

Authors:  A Foster-Barber; B Dickens; D M Ferriero
Journal:  Dev Neurosci       Date:  2001       Impact factor: 2.984

4.  Predictive value of plasma and cerebrospinal fluid tumour necrosis factor-alpha and interleukin-1 beta concentrations on outcome of full term infants with hypoxic-ischaemic encephalopathy.

Authors:  N Oygür; O Sönmez; O Saka; O Yeğin
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-11       Impact factor: 5.747

5.  Elevation of cytokine concentrations in asphyxiated neonates.

Authors:  Kaoru Okazaki; Akira Nishida; Masahiko Kato; Kunihisa Kozawa; Naoki Uga; Hirokazu Kimura
Journal:  Biol Neonate       Date:  2005-10-21

6.  Baroda development screening test for infants.

Authors:  A T Phatak; B Khurana
Journal:  Indian Pediatr       Date:  1991-01       Impact factor: 1.411

7.  Cytokine response in cerebrospinal fluid after birth asphyxia.

Authors:  K Sävman; M Blennow; K Gustafson; E Tarkowski; H Hagberg
Journal:  Pediatr Res       Date:  1998-06       Impact factor: 3.756

8.  Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF.

Authors:  R Schindler; J Mancilla; S Endres; R Ghorbani; S C Clark; C A Dinarello
Journal:  Blood       Date:  1990-01-01       Impact factor: 22.113

9.  A study of Baroda Development Screening Test for infants.

Authors:  P Phatak; M Dhapre; A N Pandit; S Kulkarni
Journal:  Indian Pediatr       Date:  1991-08       Impact factor: 1.411

10.  Pathophysiology of perinatal asphyxia: can we predict and improve individual outcomes?

Authors:  Paola Morales; Diego Bustamante; Pablo Espina-Marchant; Tanya Neira-Peña; Manuel A Gutiérrez-Hernández; Camilo Allende-Castro; Edgardo Rojas-Mancilla
Journal:  EPMA J       Date:  2011-07-26       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.